Abstract:BACKGROUND:To clarify the difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome SARS) and common atypical pneumonia.METHODS:Totally 100 patients hospitalized in Beijing Ditan Hospital since March to June 2003 with clinical diagnosis of SARS were involved in this study. These patients courses of disease were over 3 weeks. These patients were divided into two groups, SARS group and common atypical pneumonia group (non-SARS group). The counts of CD3+, CD4+ and CD8+ T-lymphocyte of two groups were systematically recorded and analyzed.RESULTS:Sixty-five of the patients were confirmed to have common type of SARS, including 26 males and 39 females, 50 cases received methylprednisolone treatment. Thirty-five cases had common atypical pneumonia (non-SARS), 21 were males while 14 were females, 20 cases received methylprednisolone treatment. All the cases of two groups were cured in the end. The SARS patients T-lymphocyte counts decreased first and then increased. Before 15 days of disease course, mean CD3+, CD4+, CD8+ T-lymphocyte counts of SARS patients were decreased apparently (694+/-568/microl, 441+/-356/microl, 309+/-462/microl). After 15th day of disease course, the counts gradually returned to normal CD3+, CD4+, CD8+ T-lymphocyte counts of non-SARS patients were normal. Compared with patients of the same group who were not treated with glucocorticoids, T-lymphocyte counts of non-SARS patients treated with glucocorticoids had no obvious difference. But glucocorticoids had some effect on SARS patients recovery of cellular immune function, i.e., it delayed the recovery by about 6 days.CONCLUSION:With or without treatment with glucocorticoids,the lowered CD3+, CD4+, CD8+ T-lymphocyte counts in the early stage are of very important significance in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia.

Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome

Rapid Loss of Both CD4+ and CD8+ T Lymphocyte Subsets During the Acute Phase of Severe Acute Respiratory Syndrome.

Dynamics of Peripheral Blood Lymphocytes and Their Subpopulations in Patients with Severe Acute Respiratory Syndrome

Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome

[Retrospective Analysis on Clinical Features of 35 Patients with Severe Acute Respiratory Syndrome].

[Dynamics of Peripheral Blood B Lymphocytes and Natural Killer Cells in Patients with Severe Acute Respiratory Syndrome].

Changes of Blood Cells in Patients with Severe Acute Respiratory Syndrome

Determination of lymphocyte subsets in severe acute respiratory syndrome cases

Measurement of the T Lymphocyte Subsets and the Th1/Th2 Cytokines in Patients with Severe Acute Respiratory Syndrome

Effects of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection on Peripheral Blood Lymphocytes and Their Subsets

[Immunological Characteristics of 1291 Cases of Severe Acute Respiratory Syndrome in Beijing].

[Difference and Significance of T-lymphocyte Subsets in Differential Diagnosis Between Severe Acute Respiratory Syndrome and Common Atypical Pneumonia].

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

The Study of B Lymphocyte and NK Cell in Severe Acute Respiratory Syndrome (SARS) Patients

Impairment of Cellular Immunity in 95 Patients with SARS and Its Relation with Cytokines

Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome

Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome.

Dynamic Changes of Viral Load and Antibodies Level in the Patients of Severe Acute Respiratory Syndrome

Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection

Clinical Laboratory Features of the Patients with SARS from Tianjin Haihe Hospital

Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID‚Äź19: Implications for disease severity and prognosis